Damien Bové brings an entrepreneurial and creative spirit to his role as Chief Regulator Officer. He leads ADACT’s team of global regulatory compliance experts for the electronic cigarette, vaping, CBD and hemp industries.

Nationality: English, Italian, Scottish
Year of birth: 1976
Education: Graduate in Pharmaceutical Sciences, Postgraduate in Frontiers of Medical Science
Family status: Married, two children
Leisure time: Surfing, climbing big hills, spending time with family and friends, going to music concerts and reading a good book

Studies

Studies

  • BSc (Hons) in Pharmaceutical Sciences at the University of Bradford (1996-2000)
  • MSc in Frontiers of Medical Science at the Open University (2001-03)
Further Training

Further Training

  • 2000: Clinical Research Overview, Covance
  • 2003: Advanced Issues in Clinical Research, Imperial College London
  • 2006: The Lifecycle of NHS Clinical Trials, ICR
  • 2010: Advanced Therapy Regulations
  • 2014: Cancer Innovation Exchange, East Midlands Academic Health Science Network (EMAHSN)
  • 2014: Module 3 dossiers for Traditional Herbal Medicinal Products (THMP), British Herbal Medicine Association (BHMA)
  • 2016: Regulation of Herbal Medicines, Callisto Consulting Ltd
Professional Career

Professional Career

  • 1998-99: Academic Liaison, SmithKline Beecham
  • 2000-01: Research Assistant to Research Associate, GlaxoSmithKline
  • 2001-02: Research Assistant to Commercial Consultant
  • 2002-03: Research Assistant to Director of Emergent Product Services
  • Since 2004: Independent consultant, Medical Technologies
  • 2009-13: Director and Regulatory Officer, IDA
  • 2013-15: Director of Product Development, Yorkshire Biotec
  • 2014: Director Innovation Centre (The HUB), Charnwood Biomedical Campus
  • Since 2012: Chief Regulatory Officer, ADACT Medical Ltd

Other Work

  • 2015-18: Regulatory Officer, European Electronic Cigarette Business Association (ECCBA)
  • Since 2000: Works with the MHRA, FDA, Health Canada, EMEA and UKVIA amongst others.
Peer review

Peer review

  • Since 2015: Cell and Gene Therapy Insights
Standards committees

Standards committees

Since May 2019: Committee member for Electronic Cigarettes and E-liquids standards (EN, CEN, ESO) at the British Standards Institute (BSI)

Memberships

Memberships

  • 2003-04: Member of the Health Economics Study Group
  • Since 2007: Registered Member of the Royal Institute of Clinical Research (ICR)
  • Since 2017: Member of the UK Vaping Industry Association (UKVIA)
  • Since 2019: Member of the Information Commissioner’s Office (ICO)
  • Since 2019: Member of The Medical Cannabis Clinicians Society (MCCS)
  • Since 2020: Member of Cooperation Centre for Scientific Research Relative to Tobacco (CORESTA)
Publications

Publications

European Neurological Review, 2012;7(Suppl 1), Mary Baker, Tom Isaacs, Reijo Salonen, Damien Bové, Ken Paterson, Angelo Antonini – https://touchneurology.com/access-through-partnership-a-stakeholder-dialogue/
23 Sept 2012: Speaking to in-PharmaTechnologist.com about Health Canada’s documents
2015-17: Guest columnist for Vapour Magazine
2017-18: Guest columnist for Vapouround magazine

Guest speaker / panelist

Guest speaker / panelist

  • 7 November 2018: Regulation and compliance, CTAUK AGM
  • 16 July 2018: All-Party Parliamentary Group to discuss vaping regulation post-Brexit
  • 25 April 2019: Novel Foods, Hemp and CBD Expo, NEC Birmingham
  • 9 May 2019: Future of vape regulations and CBD, UKVIA forum, London
  • 11 July 2019: Cannabidoil: Food Supplements Special Interest Group, Consult2deliver
  • 18 July 2019: UKVIA Board meeting, campaigning for fair and appropriate regulations
  • 28 September 2019: CEN standards meeting for chemicals in vaping, Sicily
  • 2 October 2019: ISO standards, representing UKVIA, London
  • 28 October 2019: FDA PMTA public meeting

We can help your business succeed

We care about our customers and ensuring they have access to affordable compliance services to enable their businesses to grow.

Compliance strengthens brands – consumers naturally have a higher level of confidence in tested, approved products. Compliant products have a leading edge in the market place, when compared to non-tested brands and products.

Work with scientists, work with us

Experts in science

Consult with a compliance agency with an excellent in-depth understanding of the science behind their work.

Reliable results

Our testing is completed in our own state of the art ISO 17025 accredited laboratory, providing results you can trust.

Numbers to trust

We have immense experience in providing compliance with over 1,500,000 TPD notifications since May 2016.

Get in touch today

We’re delighted to meet with you and look forward to working with you soon. Contact ADACT using the buttons below…